Blockchain Registration Transaction Record

Aclarion Q1: Nociscan scans surge 196%, AI patent expands IP moat

Aclarion reports 196% growth in Nociscan scans, AI patent, and U.K. reimbursement. Learn how this tech could revolutionize chronic low back pain diagnosis.

This news matters because chronic low back pain affects millions and often leads to ineffective treatments due to poor diagnosis. Nociscan's AI-driven platform could improve treatment success rates by pinpointing painful discs, potentially reducing unnecessary surgeries and healthcare costs. With insurers like Vitality, AXA, and Aviva covering the test, patients may soon have broader access to precise diagnostics, transforming pain management.